See All Slides - tctmd.com

Slides

Presentation TCT 2012

Therapies Based on ApoA1 and ApoA1 Milano: Overview of the Field

Presenter: Bryan Brewster

October 23, 2012

Presentation TCT 2012

ELM Presentation(4)

Presenter: Allen Jeremias

October 23, 2012

Presentation TCT 2012

Case 4: During Carotid Artery Stenting: Extracerebral or Access Vessel Related

Presenter: Fayaz Shawl

October 23, 2012

Presentation TCT 2012

Payment Reform: Prepare for the Changes

Presenter: Pamela Douglas

October 23, 2012

Presentation TCT 2012

TCT-64. Bypassing the Emergency Department is Associated with Faster Reperfusion in Patients with Pre-hospital ST-segment Elevation: Findings from the Reperfusion of Acute...

Presenter: Akshay Bagai

October 23, 2012

Presentation TCT 2012

ELM Presentation(9)

Presenter: Jennifer Tremmel

October 23, 2012

Presentation TCT 2012

Sirolimus-Eluting Stent (Svelte Medical) Program Update

Presenter: Mark Webster

October 23, 2012

Presentation TCT 2012

TCT-44. LEADERS: 5-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable...

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

History of SCAI and CCI

Presenter: Frank Hildner

October 23, 2012

Presentation TCT 2012

TCT-92. Does Mitral Regurgitation Impact the Outcome of TAVI Procedures? Insights from the FRANCE2 Registry

Presenter: Eric van Belle

October 23, 2012

Advertisement

Slides

Therapies Based on ApoA1 and ApoA1 Milano: Overview of the Field

ELM Presentation(4)

Case 4: During Carotid Artery Stenting: Extracerebral or Access Vessel Related

Payment Reform: Prepare for the Changes

TCT-64. Bypassing the Emergency Department is Associated with Faster Reperfusion in Patients with Pre-hospital ST-segment Elevation: Findings from the Reperfusion of Acute...

ELM Presentation(9)

Sirolimus-Eluting Stent (Svelte Medical) Program Update

TCT-44. LEADERS: 5-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable...

History of SCAI and CCI

TCT-92. Does Mitral Regurgitation Impact the Outcome of TAVI Procedures? Insights from the FRANCE2 Registry

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content